Literature DB >> 31161334

Clinical diversity in macular corneal dystrophy: an optical coherence tomography study.

Sunita Chaurasia1, Muralidhar Ramappa2, Dilip Kumar Mishra3.   

Abstract

PURPOSE: To characterise the corneal deposits of macular corneal dystrophy and correlate with high-resolution optical coherence tomography (OCT).
METHODS: A total of 23 eyes of 15 patients were evaluated for clinical features on slit lamp biomicroscopy, and high-resolution OCT was performed to correlate the clinical findings. The deposits were characterised based upon their location and level in the corneal layers.
RESULTS: Mean age was 31.5 (Range 20-67) years. The stromal deposits were restricted to central 8 mm in 9 eyes; in the rest of the 14 eyes, the deposits were seen in both central and peripheral cornea. In one patient, no such distinction could be made due to diffuse nature of the deposits throughout the cornea with sparing of 1-2 mm of the cornea internal to the limbus. The central deposits were in the anterior stromal layers, while the peripheral deposits were in the deep stromal corneal layers and non-contiguous with the anterior stromal deposits. In one patient aged 67 years, the peripheral deposits in deep corneal layers were more prominent than the central anterior stromal deposits and were associated with a significant thickening of Descemet membrane.
CONCLUSIONS: MCD exhibits a clinically diverse presentation as revealed on the clinical and optical coherence tomography study. Immunophenotype and genotype-phenotype correlation may further help in understanding various clinical presentations of MCD.

Entities:  

Keywords:  Corneal dystrophy; Macular corneal dystrophy; Optical coherence tomography

Mesh:

Year:  2019        PMID: 31161334     DOI: 10.1007/s10792-019-01136-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  7 in total

1.  Macular corneal dystrophy: ultrastructural pathology of corneal endothelium and Descemet's membrane.

Authors:  R C Snip; K R Kenyon; W R Green
Journal:  Invest Ophthalmol       Date:  1973-02

2.  Macular dystrophy of the cornea.

Authors:  G Morgan
Journal:  Br J Ophthalmol       Date:  1966-02       Impact factor: 4.638

3.  Phenotype and genotype analysis in patients with macular corneal dystrophy.

Authors:  Anna K Nowinska; Edward Wylegala; Sławomir Teper; Ewa Wróblewska-Czajka; Pasquale Aragona; Anna M Roszkowska; Antonio Micali; Antonina Pisani; Domenico Puzzolo
Journal:  Br J Ophthalmol       Date:  2014-06-11       Impact factor: 4.638

4.  Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan.

Authors:  J R Hassell; D A Newsome; J H Krachmer; M M Rodrigues
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

5.  Macular corneal dystrophy: mutational spectrum in German patients, novel mutations and therapeutic options.

Authors:  Claudia Gruenauer-Kloevekorn; Saskia Braeutigam; Wolfram Heinritz; Ursula G Froster; Gernot I W Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-24       Impact factor: 3.117

Review 6.  The IC3D classification of the corneal dystrophies.

Authors:  Jayne S Weiss; H U Møller; Walter Lisch; Shigeru Kinoshita; Anthony J Aldave; Michael W Belin; Tero Kivelä; Massimo Busin; Francis L Munier; Berthold Seitz; John Sutphin; Cecilie Bredrup; Mark J Mannis; Christopher J Rapuano; Gabriel Van Rij; Eung Kweon Kim; Gordon K Klintworth
Journal:  Cornea       Date:  2008-12       Impact factor: 2.651

7.  Atypical presentation of macular corneal dystrophy managed by Descemet stripping endothelial keratoplasty.

Authors:  Sunita Chaurasia; Dilip K Mishra
Journal:  Indian J Ophthalmol       Date:  2019-01       Impact factor: 1.848

  7 in total
  1 in total

1.  Detailed corneal and genetic characteristics of a pediatric patient with macular corneal dystrophy - case report.

Authors:  Anna Nowińska; Edyta Chlasta-Twardzik; Michał Dembski; Ewa Wróblewska-Czajka; Klaudia Ulfik-Dembska; Edward Wylęgała
Journal:  BMC Ophthalmol       Date:  2021-07-23       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.